Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma

BACKGROUND: We report a phase I study to examine the pharmacokinetics, safety, and recommended dosage of weekly intravenous bolus 5-fluorouracil (5-FU) in children and young adults with recurrent ependymoma. METHODS: Patients 22 years of age or less with recurrent ependymoma were treated with bolus...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Wright, Karen D., Daryani, Vinay M., Turner, David C., Onar-Thomas, Arzu, Boulos, Nidal, Orr, Brent A., Gilbertson, Richard J., Stewart, Clinton F., Gajjar, Amar
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2015
Aiheet:
Pediatric Neuro-Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4633933/
https://ncbi.nlm.nih.gov/pubmed/26541630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov181
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia